Structured evidence table for Bitter Melon Blood Glucose Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Bitter Melon Blood Glucose Meta-Analysis | Diabetes mellitus and prediabetes represent major global health challenges associated with metabolic and cardiovascular complications. | 1 | Nampalliwar A (2026) | A Systematic Review of Herbal Medicines in the Management of Diabetes: Efficacy, Toxicological Profiles, and Clinical Safety Considerations. |
| Bitter Melon Blood Glucose Meta-Analysis | This review was conducted to evaluate herbal medicines as complementary strategies for glycaemic control and metabolic risk reduction. | 1 | Nampalliwar A (2026) | A Systematic Review of Herbal Medicines in the Management of Diabetes: Efficacy, Toxicological Profiles, and Clinical Safety Considerations. |
| Bitter Melon Blood Glucose Meta-Analysis | 1 2 3 4 5 6 7 8 9 10 [11] [12] [13] 14 15 [16] [17] [18] The prevalence of cardiometabolic diseases is globally rising, and this increases the risk of cardiovascular diseases and associated mortality []. | 1 | Mkhize Sphesihle A.L. (2025) | Efficacy of Momordica charantia in glycaemic control and insulin resistance among patients with prediabetes and type 2 diabetes. A GRADE-adherent meta-analysis of randomised controlled trials |
| Bitter Melon Blood Glucose Meta-Analysis | Cardiometabolic diseases refer to a group of conditions marked by the concurrence of risk factors, including obesity, hyperglycaemia, dysregulated endocrine functions, and insulin resistance []. | 1 | Mkhize Sphesihle A.L. (2025) | Efficacy of Momordica charantia in glycaemic control and insulin resistance among patients with prediabetes and type 2 diabetes. A GRADE-adherent meta-analysis of randomised controlled trials |
| Bitter Melon Blood Glucose Meta-Analysis | This suggests that the risk of T2D is also anticipated to rise, provided the prediabetes is not adequately controlled. | 1 | Mkhize Sphesihle A.L. (2025) | Efficacy of Momordica charantia in glycaemic control and insulin resistance among patients with prediabetes and type 2 diabetes. A GRADE-adherent meta-analysis of randomised controlled trials |
Source documents